The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
The epigenetics of breast cancer
Open accessAbstract
Epigenetic changes can be defined as stable molecular alterations of a cellular phenotype such as the gene expression profile of a cell that are heritable during somatic cell divisions (and sometimes germ line transmissions) but do not involve changes of the DNA sequence itself. Epigenetic phenomena are mediated by several molecular mechanisms comprising histone modifications, polycomb/trithorax protein complexes, small non‐coding or antisense RNAs and DNA methylation. These different modifications are closely interconnected. Epigenetic regulation is critical in normal growth and development and closely conditions the transcriptional potential of genes. Epigenetic mechanisms convey genomic adaption to an environment thereby ultimately contributing towards given phenotype. In this review we will describe the various aspects of epigenetics and in particular DNA methylation in breast carcinogenesis and their potential application for diagnosis, prognosis and treatment decision.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Nan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,730
Cancer epigenomics: DNA methylomes and histone-modification maps
Esteller, M. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2005 · Cited by 2,146
The diverse functions of histone lysine methylation
Martin, C., & Zhang, Y. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1761 · Cited by 2,057
Roth, S. Y., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,845
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
d'AMOURS, D., DESNOYERS, S., d'SILVA, I., & POIRIER, G. G. (1999) · Biochemical Journal · doi:10.1042/bj3420249 · Cited by 1,815
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
Baylin, S. B., & Ohm, J. E. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1799 · Cited by 1,639
Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors
Esteller, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.564 · Cited by 1,233
Histone acetylation and an epigenetic code
Turner, B. M. (2000) · BioEssays · doi:10.1002/1521-1878(200009)22:9<836::aid-bies9>3.0.co;2-x · Cited by 1,182
Shilatifard, A. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142422 · Cited by 1,103
Dammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., & Wolffe, A. P. (2000) · Nature Genetics · doi:10.1038/77124 · Cited by 942
Histone methylation in transcriptional control
Kouzarides, T. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00287-3 · Cited by 908
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E., & Baylin, S. B. (1995) · PubMed · Cited by 796
Schübeler, D., MacAlpine, D. M., Scalzo, D., Wirbelauer, C., Kooperberg, C., van Leeuwen, F., Gottschling, D. E., O'Neill, L. P., Turner, B. M., Delrow, J., et al. (2004) · Genes & Development · doi:10.1101/gad.1198204 · Cited by 796
Ito, K., Barnes, P. J., & Adcock, I. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6891-6903.2000 · Cited by 723
An epigenetic road map for histone lysine methylation
Lachner, M., O'Sullivan, R. J., & Jenuwein, T. (2003) · Journal of Cell Science · doi:10.1242/jcs.00493 · Cited by 630
Litt, M. D., Simpson, M., Gaszner, M., Allis, C. D., & Felsenfeld, G. (2001) · Science · doi:10.1126/science.1064413 · Cited by 580
BRCA1 dysfunction in sporadic basal-like breast cancer
Turner, N. C., Reis-Filho, J. S., Russell, A. M., Springall, R. J., Ryder, K., Steele, D., Savage, K., Gillett, C. E., Schmitt, F. C., Ashworth, A., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210014 · Cited by 573
Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes
Romanov, S. R., Kozakiewicz, B. K., Holst, C. R., Stampfer, M. R., Haupt, L. M., & Tlsty, T. D. (2001) · Nature · doi:10.1038/35054579 · Cited by 560
Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin
Peters, A. H. F. M., Mermoud, J. E., O'Carroll, D., Pagani, M., Schweizer, D., Brockdorff, N., & Jenuwein, T. (2002) · Nature Genetics · doi:10.1038/ng789 · Cited by 502
Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype
Toyota, M., Ohe-Toyota, M., Ahuja, N., & Issa, J.-P. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.710 · Cited by 473
DNA methylation and breast carcinogenesis
Widschwendter, M., & Jones, P. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205606 · Cited by 457
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis
Esteller, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.26.3001 · Cited by 441
Bachman, K. E., Rountree, M. R., & Baylin, S. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104661200 · Cited by 438
Furumai, R., Komatsu, Y., Nishino, N., Khochbin, S., Yoshida, M., & Horinouchi, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.87 · Cited by 412
Frigola, J., Song, J., Stirzaker, C., Hinshelwood, R. A., Peinado, M. A., & Clark, S. J. (2006) · Nature Genetics · doi:10.1038/ng1781 · Cited by 409
Methylation of the BRCA1 gene in sporadic breast cancer.
Dobrovic, A., & Simpfendorfer, D. (1997) · PubMed · Cited by 370
Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR
Evron, E., Dooley, W. C., Umbricht, C. B., Rosenthal, D., Sacchi, N., Gabrielson, E., Soito, A. B., Hung, D. T., Ljung, B.-M., Davidson, N. E., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04501-3 · Cited by 333
Widschwendter, M., Siegmund, K. D., Müller, H. M., Fiegl, H., Marth, C., Müller-Holzner, E., Jones, P. A., & Laird, P. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3852 · Cited by 324
DNA methylation in serum of breast cancer patients: an independent prognostic marker.
Müller, H. M., Widschwendter, A., Fiegl, H., Ivarsson, L., Goebel, G., Perkmann, E., Marth, C., & Widschwendter, M. (2003) · PubMed · Cited by 317
Wade, P. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.693 · Cited by 317
(2003) · PubMed · Cited by 313
Ferguson, A. T., Lapidus, R. G., Baylin, S. B., & Davidson, N. E. (1995) · PubMed · Cited by 297
Dammann, R., Yang, G., & Pfeifer, G. P. (2001) · PubMed · Cited by 280
Seraj, M. J., Samant, R. S., Verderame, M. F., & Welch, D. R. (2000) · PubMed · Cited by 265
Methylation and Silencing of the Retinoic Acid Receptor- 2 Gene in Breast Cancer
Widschwendter, M., Berger, J., Hermann, M., Muller, H. M., Amberger, A., Zeschnigk, M., Widschwendter, A., Abendstein, B., Zeimet, A. G., Daxenbichler, G., et al. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.10.826 · Cited by 259
Paredes, J., Albergaria, A., Oliveira, J. T., Jerónimo, C., Milanezi, F., & Schmitt, F. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0059 · Cited by 257
Fackler, M. J., McVeigh, M., Evron, E., Garrett, E., Mehrotra, J., Polyak, K., Sukumar, S., & Argani, P. (2003) · International Journal of Cancer · doi:10.1002/ijc.11508 · Cited by 253
Fiegl, H., Millinger, S., Mueller-Holzner, E., Marth, C., Ensinger, C., Berger, A., Klocker, H., Goebel, G., & Widschwendter, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2438 · Cited by 252
Lapidus, R. G., Ferguson, A. T., Ottaviano, Y. L., Parl, F. F., Smith, H. S., Weitzman, S. A., Baylin, S. B., Issa, J. J., & Davidson, N. E. (1996) · PubMed · Cited by 250
Regional copy number–independent deregulation of transcription in cancer
Stransky, N., Vallot, C., Reyal, F., Bernard-Pierrot, I., de Medina, S. G. D., Segraves, R., de Rycke, Y., Elvin, P., Cassidy, A., Spraggon, C., et al. (2006) · Nature Genetics · doi:10.1038/ng1923 · Cited by 250
Evron, E., Umbricht, C. B., Korz, D., Raman, V., Loeb, D. M., Niranjan, B., Buluwela, L., Weitzman, S. A., Marks, J. R., & Sukumar, S. V. (2001) · PubMed · Cited by 249
Fan, M., Yan, P. S., Hartman-Frey, C., Chen, L., Paik, H., Oyer, S. L., Salisbury, J. D., Cheng, A. S. L., Li, L., Abbosh, P. H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1666 · Cited by 248
Detection of Aberrant Methylation of Four Genes in Plasma DNA for the Detection of Breast Cancer
Hoque, M. O., Feng, Q., Toure, P., Dem, A., Critchlow, C. W., Hawes, S. E., Wood, T., Jeronimo, C., Rosenbaum, E., Stern, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.3516 · Cited by 244
Cell type-specific DNA methylation patterns in the human breast
Bloushtain-Qimron, N., Yao, J., Snyder, E. L., Shipitsin, M., Campbell, L. L., Mani, S. A., Hu, M., Chen, H., Ustyansky, V., Antosiewicz, J. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805206105 · Cited by 241
Quantitative Assessment of Promoter Hypermethylation during Breast Cancer Development
Lehmann, U., Länger, F., Feist, H., Glöckner, S., Hasemeier, B., & Kreipe, H. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64880-8 · Cited by 222
Saunders, M. M., Seraj, M. J., Li, Z., Zhou, Z., Winter, C. R., Welch, D. R., & Donahue, H. J. (2001) · PubMed · Cited by 206
De Smet, C., Loriot, A., & Boon, T. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4781-4790.2004 · Cited by 192
Mancini, D. N., Rodenhiser, D. I., Ainsworth, P. J., O'Malley, F. P., Singh, S. M., Xing, W., & Archer, T. K. (1998) · Oncogene · doi:10.1038/sj.onc.1201630 · Cited by 190
Huschtscha, L. I., Noble, J. R., Neumann, A. A., Moy, E. L., Barry, P. A., Melki, J. R., Clark, S. J., & Reddel, R. R. (1998) · PubMed · Cited by 186
Gupta, A., Godwin, A. K., Vanderveer, L., et al. (2003) · PubMed · Cited by 184
Lo, P.-K., & Sukumar, S. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.12.1879 · Cited by 184
Pakneshan, P., Szyf, M., Farias-Eisner, R., & Rabbani, S. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401669200 · Cited by 184
Histone acetylation beyond promoters: long‐range acetylation patterns in the chromatin world*
Forsberg, E. C., & Bresnick, E. H. (2001) · BioEssays · doi:10.1002/bies.1117 · Cited by 182
Mutational spectra of human cancer
Pfeifer, G. P., & Besaratinia, A. (2009) · Human Genetics · doi:10.1007/s00439-009-0657-2 · Cited by 178
Detection of Breast Cancer in Nipple Aspirate Fluid by CpG Island Hypermethylation
Krassenstein, R., Sauter, E., Dulaimi, E., Battagli, C., Ehya, H., Klein-Szanto, A., & Cairns, P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0410-3 · Cited by 171
Meehan, W. J., Samant, R. S., Hopper, J. E., Carrozza, M. J., Shevde, L. A., Workman, J. L., Eckert, K. A., Verderame, M. F., & Welch, D. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307969200 · Cited by 170
Munster, P. N., Marchion, D., Thomas, S., Egorin, M., Minton, S., Springett, G., Lee, J.-H., Simon, G., Chiappori, A., Sullivan, D., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605293 · Cited by 167
Muggerud, A. A., Rønneberg, J. A., Wärnberg, F., Botling, J., Busato, F., Jovanovic, J., Solvang, H., Bukholm, I., Børresen-Dale, A.-L., Kristensen, V. N., et al. (2010) · Breast Cancer Research · doi:10.1186/bcr2466 · Cited by 160
Self-citationDNA methyltransferase inhibitors: old and new drugs for an epigenetic cancer therapy
Brueckner, B., & Lyko, F. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.09.004 · Cited by 159
Martens, J. W. M., Nimmrich, I., Koenig, T. W., Look, M. P., Harbeck, N., Model, F., Kluth, A., Vries, J. B., Sieuwerts, A. M., Portengen, H., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0064 · Cited by 159
Agglomerative Epigenetic Aberrations Are a Common Event in Human Breast Cancer
Novák, P., Jensen, T. J., Oshiro, M. M., Watts, G. S., Kim, C. J., & Futscher, B. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1419 · Cited by 158
Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells
Billam, M., Sobolewski, M. D., & Davidson, N. E. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0420-3 · Cited by 158
Correlation between CpG methylation profiles and hormone receptor status in breast cancers
Feng, W., Shen, L., Wen, S., Rosen, D. G., Jelı́nek, J., Hu, X., Huan, S., Huang, M. L., Liu, J., Şahin, A. A., et al. (2007) · Breast Cancer Research · doi:10.1186/bcr1762 · Cited by 154
Overexpression and Hypomethylation of Flap Endonuclease 1 Gene in Breast and Other Cancers
Singh, P., Yang, M., Dai, H., Yu, D., Huang, Q. M., Tan, W., Kernstine, K. H., Lin, D., & Shen, B. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0269 · Cited by 148
Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases
Stark, A. M., Tongers, K., Maass, N., Mehdorn, H. M., & Held‐Feindt, J. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0629-9 · Cited by 147
Dejeux, E., Rønneberg, J. A., Solvang, H. K., Bukholm, I. K., Geisler, S. B., Aas, T., Gut, I. G., Børresen‐Dale, A., Lønning, P. E., Kristensen, V. N., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-68 · Cited by 143
Self-citationHIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells
Krop, I. E., Sgroi, D. C., PORTER, D. A., Lunetta, K. L., LeVangie, R., Seth, P., Kaelin, C. M., Rhei, E., Bosenberg, M., Schnitt, S. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171138398 · Cited by 141
From DNA damage and stress signalling to cell death : poly-ADP-ribosylation reactions
de MURCIA, G., & Shall, S. (2000) · Medical Entomology and Zoology · Cited by 134
Early detection of breast cancer based on gene-expression patterns in peripheral blood cells
Sharma, P., Sahni, N. S., Tibshirani, R. J., Skaane, P., Urdal, P., Berghagen, H., Jensen, M., Kristiansen, L., Moen, C., Sharma, P., et al. (2005) · Breast Cancer Research · doi:10.1186/bcr1203 · Cited by 134
Biomarkers for early detection of breast cancer: What, when, and where?
LEVENSON, V (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.01.017 · Cited by 131
Epigenetic Inactivation of the HOXA Gene Cluster in Breast Cancer
Novák, P., Jensen, T. J., Oshiro, M. M., Wozniak, R. J., Nouzová, M., Watts, G. S., Klimecki, W. T., Kim, C., & Futscher, B. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2761 · Cited by 123
Chekhun, V. F., Lukianova, N. Y., Kovalchuk, O., Tryndyak, V., & Pogribny, I. P. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0663 · Cited by 123
Fackler, M. J., Malone, K., Zhang, Z., Schilling, E., Garrett-Mayer, E. S., Swift‐Scanlan, T., Lange, J. R., Nayar, R., Davidson, N. E., Khan, S. A., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2733 · Cited by 122
Methylated genes as new cancer biomarkers
Duffy, M. J., Napieralski, R., Martens, J. W. M., Span, P. N., Spyratos, F., Sweep, F. C. G. J., Brünner, N., Foekens, J. A., & Schmitt, M. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.12.008 · Cited by 117
Gene expression profiling of peripheral blood cells for early detection of breast cancer
Aarøe, J., Lindahl, T., Dumeaux, V., Sæbø, S., Tobin, D., Hagen, N., Skaane, P., Lönneborg, A., Sharma, P., & Børresen‐Dale, A. (2010) · Breast Cancer Research · doi:10.1186/bcr2472 · Cited by 117
Breast cancer epigenetics: normal human mammary epithelial cells as a model system
Hinshelwood, R. A., & Clark, S. J. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0386-3 · Cited by 116
Samant, R. S., Clark, D. W., Fillmore, R. A., Cicek, M., Metge, B. J., Chandramouli, K. H., Chambers, A. F., Casey, G., Welch, D. R., & Shevde, L. A. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-6 · Cited by 115
Cicek, M., Fukuyama, R., Welch, D. R., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3139 · Cited by 115
Liu, Y., Smith, P. W., & Jones, D. R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00940-06 · Cited by 115
Hypermethylation in Histologically Distinct Classes of Breast Cancer
Bae, Y. K., Brown, A. L., Garrett, E., Bornman, D. M., Fackler, M. J., Sukumar, S. V., Herman, J. G., & Gabrielson, E. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0667 · Cited by 112
Hartmann, O., Spyratos, F., Harbeck, N., Dietrich, D., Faßbender, A., Schmitt, M., Eppenberger‐Castori, S., Vuaroqueaux, V., Lerebours, F., Welzel, K., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0166 · Cited by 108
Histone Deacetylase Inhibitors for Cancer Therapy
Kim, T., Bang, Y., & Robertson, K. D. (2006) · Epigenetics · doi:10.4161/epi.1.1.2644 · Cited by 106
Analysis of mechanisms underlying BRMS1 suppression of metastasis
Samant, R. S., Seraj, M. J., Saunders, M. M., Sakamaki, T., Shevde, L. A., Harms, J. F., Leonard, T. O., Goldberg, S. F., Budgeon, L. R., Meehan, W. J., et al. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1013124725690 · Cited by 100
Shann, Y., Cheng, C., Chiao, C.-H., Chen, D.-T., Li, P.-H., & Hsu, M. (2008) · Genome Research · doi:10.1101/gr.070961.107 · Cited by 99
Retinoid chemoprevention of aerodigestive cancer: From basic research to the clinic
Hong, W. K. (1995) · Lung Cancer · doi:10.1016/0169-5002(96)84218-8 · Cited by 96
Covalent modifications of histones during mitosis and meiosis
Xu, D., Bai, J., Duan, Q., Costa, M., & Dai, W. H. (2009) · Cell Cycle · doi:10.4161/cc.8.22.9908 · Cited by 95
Yuan, J., Luo, R. Z.-T., Fujii, S., Wang, L., Hu, W., Andreeff, M., Pan, Y., Kadota, M., Oshimura, M., Şahin, A. A., et al. (2003) · PubMed · Cited by 95
Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma.
Weigel, R. J., & deConinck, E. C. (1993) · PubMed · Cited by 83
Chekhun, V. F., Kulik, G. I., Yurchenko, O. V., Tryndyak, V., Todor, I. N., Luniv, L. S., Tregubova, N. A., Pryzimirska, T. V., Montgomery, B. A., Rusetska, N., et al. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.01.038 · Cited by 81
Epigenetic Regulation as a New Target for Breast Cancer Therapy
Stearns, V., Zhou, Q. Y., & Davidson, N. E. (2007) · Cancer Investigation · doi:10.1080/07357900701719234 · Cited by 74
DNA Hypermethylation of ESR1 and PGR in Breast Cancer: Pathologic and Epidemiologic Associations
Gaudet, M. M., Campan, M., Figueroa, J. D., Yang, X. R., Lissowska, J., Pepłońska, B., Brinton, L. A., Rimm, D. L., Laird, P. W., García‐Closas, M., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0678 · Cited by 72
Detection of gene promoter hypermethylation in fine needle washings from breast lesions.
Jerónimo, C., Costa, I., Martins, M. C., Monteiro, P., Lisboa, S., Palmeira, C., Henrique, R., Teixeira, M. R., & Lopes, C. (2003) · PubMed · Cited by 72
The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer
Shah, R., Smith, P., Purdie, C. A., Quinlan, P., Baker, L., Åman, P., Thompson, A. M., & Crook, T. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605042 · Cited by 71
Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone
Hurst, D. R., Mehta, A., Moore, B. P., Phadke, P. A., Meehan, W. J., Accavitti, M. A., Shevde, L. A., Hopper, J. E., Xie, Y., Welch, D. R., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.005 · Cited by 69
HIN-1, an Inhibitor of Cell Growth, Invasion, and AKT Activation
Krop, I. E., Parker, M. T., Bloushtain-Qimron, N., PORTER, D. A., Gelman, R. S., Sasaki, H., Maurer, M. S., Terry, M. B., Parsons, R. E., & Polyák, K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1663 · Cited by 64
Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer
Metge, B. J., Frost, A. R., KING, J. A. C., Dyess, D. L., Welch, D. R., Samant, R. S., & Shevde, L. A. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9187-x · Cited by 63
Histone deacetylase inhibitor induced modulation of anti-estrogen therapy
Thomas, S., & Münster, P. N. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.12.026 · Cited by 56
Methylated NEUROD1 Promoter is a Marker for Chemosensitivity in Breast Cancer
Fiegl, H., Jones, A., Hauser‐Kronberger, C., Hutarew, G., Reitsamer, R., Jones, R. L., Dowsett, M., Mueller‐Holzner, E., Windbichler, G. H., Daxenbichler, G., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4557 · Cited by 42
Hurtubise, A., & Momparler, R. L. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0225-6 · Cited by 41
Paro, R. (2000) · Nature · doi:10.1038/35020675 · Cited by 26
Emerging treatment combinations: Integrating therapy into clinical practice
Wong, S. T.-L. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp090439 · Cited by 24
A role for poly(ADP-ribosyl)ation in DNA methylation
Zardo, G., Reale, A., MATTEIS, G. D., Buontempo, S., & Caiafa, P. (2003) · Biochemistry and Cell Biology · doi:10.1139/o03-050 · Cited by 20
Cited by
Hon, G. C., Hawkins, R. D., Caballero, O. L., Lo, C., Lister, R., Pelizzola, M., Valsesia, A., Ye, Z., Kuan, S., Edsall, L. E., et al. (2012) · Genome Research · doi:10.1101/gr.125872.111 · Cited by 583
Biological embedding of early‐life exposures and disease risk in humans: a role for DNA methylation
Demetriou, C. A., van Veldhoven, K., Relton, C., Stringhini, S., Kyriacou, K., & Vineis, P. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12406 · Cited by 95
Metadata
- Authors
- Jovanovic, J., Rønneberg, J. A., Tost, J., & Kristensen, V.
- Venue
- Molecular Oncology
- Publisher
- Wiley
- Published
- 2010-04-29
- Volume
- 4
- Issue
- 3
- Pages
- 242-254
- ISSN
- 1574-7891 (ISSN-L)
- 1878-0261
- OpenAlex
- W2118540634
- Cited by
- 298
- References
- 113
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.